Research Article

Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women

Table 1

Baseline characteristics of polycystic ovary syndrome (PCOS) and healthy women.

CharacteristicsPCOS women
(n=42)
Healthy women
(n=21)
Pvalue

Age (years)27.71 ± 5.2331.40 ± 5.790.013
WC (cm)84.81 ± 14.7082.48 ± 12.640.537
BMI (kg/ m2)27.05 ± 6.5925.79 ± 5.130.448
T (ng/mL)42.36 ± 21.5830.62 ± 11.320.023
SHBG (nmol/L)36.16 ± 36.6743.21 ± 24.660.043
FAI8.05 ± 8.173.92 ± 4.070.009
FBG (mg/dL)87.17 ± 9.6184.71 ± 7.940.317
2hr Glucose (mg/dL)112.55 ± 44.6291.62 ± 25.810.052
Insulin (uIU/mL)20.65 ± 23.3512.56 ± 10.510.136
HOMA-IR4.51 ± 4.972.75 ± 2.510.134
AST (U/L)22.86 ± 7.8619.52 ± 4.230.075
ALT (U/L)25.62 ± 16.2223.14 ± 22.060.220
γ-GT (U/L)25.02 ± 16.6020.71 ± 7.850.535
ALP (U/L)68.12 ± 16.9758.21 ± 18.320.615
ALB (g/L)37.65 ± 2.0038.07 ± 2.210.457
TG (mg/dL)104.31 ± 71.9484.71 ± 36.590.246
TC (mg/dL)199.0 ± 38.67205.48 ± 34.530.519
HDL-C (mg/dL)50.76 ± 13.6950.86 ± 10.880.978
LDL-C (mg/dL)134.00 ± 35.47141.05 ± 32.060.446
TSH (uIU/mL)1.83 ± 0.931.70 ± 0.930.607
PRL (ng/mL)17.13 ± 9.5423.54 ± 17.370.127
FSH (mIU/mL)4.11 ± 1.514.06 ± 1.530.898
Metabolic syndrome (n,%)6 (14.29)3 (14.29)1.000

Note: WC, waist circumference; BMI, body mass index; T, total testosterone; SHBG, sex hormone-binding globulin; FAI, free androgen index; FBG, fasting blood glucose; HOMA-IR, homeostatic model assessment of insulin resistance; AST, aspartate; ALT, alanine aminotransferase; γ-GT, γ-glutamyltransaminase; ALP, alkaline phosphatase; ALB, albumin; TG, total cholesterol; TC, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TSH, thyroid-stimulating hormone; PRL, prolactin; FSH, follicle-stimulating hormone; PCOS, polycystic ovary syndrome. P<0.05 was considered statistically significant. Values are expressed as mean±SD or number, percentage (n, %).